Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT05406167 · ClinicalTrials.gov registry record
Prospective Data Registry and Quality of Life Assessment of Patients Undergoing Radiotherapy With the RefleXion Medical Radiotherapy System
A clinical trial of Cancer and Cancer Central Nervous System, sponsored by RefleXion Medical.
- Recruiting
- Registry status
- 500
- Enrollment target
- 5
- Study locations
NCT05406167: Recruiting study of Cancer and Cancer Central Nervous System, sponsored by RefleXion Medical.
NCT05406167 is a study of Cancer and Cancer Central Nervous System that is actively recruiting participants, run by RefleXion Medical. The registered enrollment target is 500 participants, below the 3,490-participant average among 615 other Cancer trials with a reported enrollment target (86% lower). The trial reports 5 study locations across 4 states. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT05406167, a study of Cancer and Cancer Central Nervous System, is actively recruiting participants, sponsored by RefleXion Medical.
- RECRUITING
- Registry status
- 500 participants
- Enrollment target
- 5
- Study locations
Study Summary
The purpose of this prospective cohort study is to assess clinical and quality of life measures as well as to define the severity of adverse effects for the use of the RefleXion system to deliver intensity-modulated radiotherapy (IMRT), stereotactic body radiotherapy (SBRT), or SCINTIX Biology-guided radiotherapy (BgRT) in standard of care (SOC) use in the treatment of local,loco-regionally advanced, and oligometastatic malignancies. In addition, patient costs and charges will be analyzed to quantify the health economic impact of this modality. Workflow and quality of radiotherapy planning including a collection of dosimetric data will also be analyzed.
Primary Outcome
Evaluate patient-reported quality of life after IMRT, SBRT, or BgRT treatment delivered by the RefleXion system by assessing EORTC QLQ-C30. The EORTC questionnaire has a scoring of 0 to 100 and is disease-specific. 0 is none/minimal symptoms and normal/good functional ability. 100 is increased/severe symptoms and decrease/poor functional ability.
Conditions Studied
Interventions
- DEVICE Registry - Observational
Study Locations (5)
California
- City Of Hope - Duarte
- Stanford Cancer Center - Palo Alto
Connecticut
- Yale University - Cancer Center - New Haven
Pennsylvania
- University of Pittsburgh Medical Center - Pittsburgh
Texas
- UT Southwestern - Dallas
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 500 participants |
| Start Date | 2022-04-12 |
| Est. Completion | 2026-04-25 |
What NCT05406167 shows while recruiting
NCT05406167 is an observational study that tracks outcomes without assigning an intervention. The registered 500 participants enrollment target is mid-sized for trials with a published cap, below the 3,490-participant average among 615 other Cancer trials with a reported enrollment target (86% lower).
The record links to 8 conditions, with Cancer appearing as the primary indexed condition, and to 1 intervention - of which Registry - Observational is the first listed.
NCT05406167 lists 5 locations in 4 states (California, Connecticut, Pennsylvania).
Frequently Asked Questions
What is clinical trial NCT05406167 about?
NCT05406167 is a clinical study titled "Prospective Data Registry and Quality of Life Assessment of Patients Undergoing Radiotherapy With the RefleXion Medical Radiotherapy System". The purpose of this prospective cohort study is to assess clinical and quality of life measures as well as to define the severity of adverse effects for the use of the RefleXion system to deliver intensity-modulated radiotherapy (IMRT), stereotactic body radiotherapy (SBRT), or SCINTIX Biology-guide...
What is the current status of trial NCT05406167?
This trial is currently recruiting. The enrollment target is 500 participants. The study started on 2022-04-12. Estimated completion is 2026-04-25.
What conditions does trial NCT05406167 study?
This clinical trial studies the following conditions: Cancer, Cancer Central Nervous System, Cancer Thoracic, Cancer, Gastrointestinal, Cancer Gynecologic.
What interventions are being tested in trial NCT05406167?
The interventions under investigation include: Registry - Observational (DEVICE).
Who is sponsoring clinical trial NCT05406167?
This trial is sponsored by RefleXion Medical, which has 2 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT05406167 being conducted?
This trial has 5 study locations across California, Connecticut, Pennsylvania, Texas. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Cancer
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT05406167's enrollment target sits among peer trials
500 122nd of 615 higher than 484 of 615 other Cancer trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Cancer trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
-
Registry Study to Evaluate the Clinical Outcome of Cancer Patients and Benign Diseases Treated with Radiation
RECRUITING
-
Treatment of Immune Checkpoint Inhibitor-related Diarrhea and/ or Colitis With Ustekinumab in Cancer Patients
RECRUITING · Phase 2
-
IMPACT (IMproving Proactive Approaches for Cancer Survivors' Mental Health Treatment)
RECRUITING · NA
-
A Natural History Study of Metabolic Sizing in Health and Disease
RECRUITING
-
Development of Radiation Free Whole Body Magnetic Resonance (MR) Imaging Technique for Staging Children With Cancer
RECRUITING · Phase 1
-
Long-Term Follow-Up of Recipient of Gene Transfer Research
RECRUITING
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT00001230 · 500 participants
Host Response to Infection and Treatment in Filarial Diseases
- NCT00001529 · 500 participants
Improved Methods of Cell Selection for Bone Marrow Transplant Alternatives
- NCT00697411 · 500 participants
Study of Selected X-Linked Disorders: Aicardi Syndrome
- NCT00903110 · 500 participants
Global Patient Registry to Monitor Long-term Safety and Effectiveness of Increlex® in Children and Adolescents With Severe Primary Insulin-like Growth Factor-1 Deficiency (SPIGFD).
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI